Build our key opinion leader (KOL) and healthcare provider (HCP) base during early pre-launch and post-launch phases of transformative medicines in rare diseases.
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.
BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.
At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.
To learn more about our story and company culture, visit us at https://bridgebio.com
You will report to the Senior Medical Director, Europe Central Region, and work closely with fellow Medical Science Liaisons, local Market Access, and regional and global Medical Affairs teams. Together, you will execute the Medical Affairs brand plan and strategic initiatives that support BridgeBio’s mission to deliver transformative medicines for patients with genetic diseases and genetically driven cancers.
Your primary purpose will be to build our KOL and HCP base in the pre-launch and launch phase, as BridgeBio engages with most customers in Germany for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder.
This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition. We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.
The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow.
This is a Germany-based, field-facing role with a strong customer engagement component. The position requires travel throughout Germany, as well as periodic travel across Europe for conferences, KOL meetings, and speaker programs. Local team meetings and designated office location in Germany is Munich.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Rewarding Those Who Make the Mission Possible
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
Flexible Work Hours
Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
Health Insurance
100% employer-paid medical, dental, and vision premiums for you and your dependents
Commuter benefits
Pre-tax commuter benefits (transit and parking)
Paid Parental Leave
Comprehensive paid medical and parental leave to care for yourself and your family
Paid Time Off
Flexible, “take-what-you-need” paid time off and company-paid holidays
BridgeBio Pharma is a biopharmaceutical company focused on discovering and delivering transformative medicines for genetic diseases and genetically defined cancers. Utilizing a 'moneyball for biotech' approach, we minimize risk and drive innovation through small expert teams, creating a robust portfolio of over 20 drug development programs to address unmet medical needs.
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!